Latest in Cardiology from ACC.org

• ACC Quality Summit Abstract Winners Explore AUC Discrepancies, Sex Differences in LAAO Outcomes, SDOH Screening
  With a record-breaking number of abstract submissions, the quality improvement projects presented at ACC Quality Summit 2026 reflect an ongoing commitment to improve cardiovascular care through innovation, collaboration and quality. Read on for highlights from the top ePosters.
• ACC CardiaCast: Future Directions in ATTR-CM Treatment
  In this CardiaCast episode, Kevin M. Alexander, MD is joined by Sarah Cuddy, MBBCh, to discuss the latest clinical data for investigational therapies and available treatments for transthyretin amyloid cardiomyopathy (ATTR-CM), as well as the potential implications of these findings on clinical practice and future clinical studies.
• ACC Names ACC.28 and ACC.29 CV Team Lead
  The ACC has named Maureen Knechtel, DMSc, PA-C, as the Annual Scientific Session Cardiovascular (CV) Team Lead for ACC.28 and ACC.29. In her new role, she will help guide the development of educational content and programming that highlights the vital contributions of the entire cardiovascular care team and supports interprofessional collaboration across the ACC community.
• Addressing Structural CV Workforce Changes: Declining Density, Rapid Aging, Deteriorating Renewal Balance
  Population aging is expected to increase demand for cardiovascular care in the U.S., and a recent report published in JACC: Advances found that cardiologists per 100,000 U.S. population declined alongside substantial workforce aging, despite modest increases in total cardiologist numbers.
• SDOH Advisory Shows Prevalence of CVD to Increase by 2050 in US
  Most major cardiovascular disease risk factors and conditions will increase by 2050 in the U.S., with disparities remaining most pronounced among lower-income populations, people with less education, and Medicare and Medicaid beneficiaries, according to a Social Drivers of Health (SDOH) Advisory published in JACC: Advances.